Terumo Corporation 주요 수익원은 Cardiac and Vascular Company이며, 최신 수익 발표에서 수익은 676,421,000,000입니다. 지역별로는 Americas이 Terumo Corporation의 주요 시장이며, 수익은 443,405,000,000입니다.
Terumo Corporation은 수익성이 있나요?
no, 최신 재무제표에 따르면 Terumo Corporation의 순손실은 $0입니다.
Terumo Corporation에 부채가 있나요?
no, Terumo Corporation의 부채는 0입니다.
Terumo Corporation의 발행 주식은 몇 주인가요?
Terumo Corporation의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$13.25
시가
$13.75
일일 범위
$13.62 - $13.75
52주 범위
$12.08 - $19.6
거래량
14.1K
평균 거래량
189.1K
배당수익률
--
EPS(TTM)
0.57
시가총액
$20.2B
Terumo Corp.란 무엇인가요?
Terumo Corp. engages in the manufacture and sale of medical products and equipment. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 30,689 full-time employees. The firm operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.